Publications
Leukemia Insights is a quarterly newsletter for physicians and other health professionals. Insights has the latest leukemia news, research and results from ongoing clinical trials, as well as available leukemia programs at MD Anderson.
Spring 2013: Vol. 18, No. 1
What’s Next Beyond Ruxolitinib for Primary Myelofibrosis?
- Introduction
- Combination Studies of Ruxolitinib
- SAR302503 (Formerly TG101348)
- Lestaurtinib (CEP701)
- Pacritinib (SB1518)
- CYT387
- Leukemia Priorities
- XL-019
- LY2784544
- BMS-911543
- NS-018
- Conclusion
Insights Staff
Editor: Hagop Kantarjian, M.D.
WebMaster: Charles A. Koller, M.D.
Associate Editor: Sherry Pierce, R.N.
Administrator: Vicky Zoeller
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- How You Can Help
- Children's Art Project
- Directory
- Contact Us
- Sitemap
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children’s Cancer Hospital
- Services & Amenities
- Clinical Trials
- News and Publications
- Newsroom
- Publications
- Education and Research
- Departments, Programs & Labs
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- State of Texas
- State of Texas Home Page
- Statewide Search (TRAIL)
- State Comptroller - Where the Money Goes
- Texas Homeland Security
- The University of Texas System
- Institution Resume
- Legal and Policy
- Legal Statements & Site Policies
- Stay Connected
- Emergency Alerts
- Emergency Alert Information
© 2013 The University of Texas MD Anderson Cancer Center